Deep Immune, an early lung cancer monitoring platform, is equipped with an immunotherapy programme based on TCR observation technology and deep learning algorithms, which enables accurate early detection of cancer through immunomic data analysis.

Based on deep learning and a reinforcement learning algorithm, the product can determine the probability of the occurrence of lung cancer by analysing tissue and blood sample data.

The product intelligently generates analysis reports, which greatly reduce the complexity and diagnosis cost of early lung cancer screening and improve the survival probability of patients. The deep learning model has reached 97% accuracy.